Jiuzhitang Co., Ltd.

000989

CNE000001394

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
6.67 ^CNY	+0.30%		-14.92%	-34.09%

May. 20	Jiuzhitang Co., Ltd. Approves Final Cash Dividend for the Year 2023	CI
May. 08	Jiuzhitang Co., Ltd.(XSEC:000989) dropped from S&P Global BMI Index	CI

Jiuzhitang Co., Ltd.(XSEC:000989) dropped from FTSE All-World Index

March 22, 2021 at 12:00 am EDT

Jiuzhitang Co., Ltd.(XSEC:000989) dropped from FTSE All-World Index (USD)

Latest news about Jiuzhitang Co., Ltd.

Jiuzhitang Co., Ltd. Approves Final Cash Dividend for the Year 2023	May. 20	CI
Jiuzhitang Co., Ltd.(XSEC:000989) dropped from S&P Global BMI Index	May. 07	CI
Jiuzhitang Co., Ltd. Proposes Final Cash Dividend (Tax Included) for 2023	Apr. 24	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 24	CI
Tranche Update on Jiuzhitang Co., Ltd.'s Equity Buyback Plan announced on March 19, 2024.	Apr. 02	CI
Jiuzhitang Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	Mar. 18	CI
Jiuzhitang Co., Ltd. authorizes a Buyback Plan.	Mar. 17	CI
Jiuzhitang's Unit to Launch Clinical Trials Into Human Bone Marrow Stem Cell Injection; Shares Drop 3%	Nov. 02	MT
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-07	CI
Jiuzhitang Unit to Hold Clinical Trial Into Stem Cell Treatment	23-06-12	MT
Jiuzhitang Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 06 June 2023	23-05-30	CI
Jiuzhitang Co., Ltd. Approves Cash Dividend for the Year 2022	23-05-25	CI
Jiuzhitang Co., Ltd. Proposes Final Cash Dividend for 2022	23-05-04	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Jiuzhitang Co., Ltd. Appoints Bo Jinfeng as Non-Independent Director	23-01-11	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Jiuzhitang Cleared to Launch Clinical Trial of Deep Vein Thrombosis Drug	22-09-22	MT
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-30	CI
Jiuzhitang Co., Ltd. Appoints Wang Yonghui as a Non-Independent Director	22-08-17	CI
Jiuzhitang Co., Ltd. Announces Final Cash Dividend for 2021 Payable on 01 June 2022	22-05-26	CI
Yifeng Pharmacy Chain Co., Ltd. completed the acquisition of a 51% stake in Hunan Jiuzhitang Pharmaceutical Co., Ltd. from Jiuzhitang Co., Ltd..	22-05-25	CI
Jiuzhitang Co., Ltd. Announces Final Cash Dividend for 2021	22-05-23	CI
Jiuzhitang Co., Ltd. Proposes Profit Distribution for 2021	22-04-25	CI
Yifeng Pharmacy Chain Co., Ltd. agreed to acquire 5% stake in Jiuzhitang Co., Ltd. from Li Zhenguo for CNY 430 million.	22-04-24	CI

JIUZHITANG CO.,Ltd. is a China-based company principally engaged in the research, development, production and distribution of Chinese patent drugs. The Company provides products through three categories, which include over the counter (OTC) drugs, prescription drugs and comprehensive health series. The Companyâs main products include Liuwei Dihuang pills, Xiaoyao pills, Shuxuetong injection, compound Jiangzhi tablets and E-Jiao series health products, among others. The Company distributes its products in domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-29 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
JIUZHITANG CO., LTD.	-34.09%	788M
DONG-E-E-JIAO CO.,LTD.	+37.29%	6.02B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-21.28%	4.19B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+4.52%	3.25B
TASLY PHARMACEUTICAL GROUP CO., LTD	-18.16%	2.87B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-7.70%	2.37B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.50%	1.89B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.05%	1.58B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-15.56%	1.54B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.62%	1.5B